Fairvalue-Calculator Fairvalue-Calculator
EN DE

THX Pharma Société Anonyme, a biopharmaceutical company, (ALTHX) Fair Value & Analysis

Healthcare · FR · Market cap €54.0M

Price€3.32
Fair Value€0.6200
Upside-81.3%
Quality82/100
Evidence: Low Range €0.4600 – €0.7700

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

THX Pharma Société Anonyme, a biopharmaceutical company, (ALTHX) currently trades at €3.32, while our model-based Fair Value estimate is €0.6200 — implying the stock looks roughly 81.3% overvalued today. We read business quality at 82/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is THX Pharma Société Anonyme, a biopharmaceutical company, (ALTHX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €0.6200 versus a price of €3.32 — about −81% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALTHX?
Our 21-model fair value for THX Pharma Société Anonyme, a biopharmaceutical company, is €0.6200 (as of Jun 24, 2026), built from audited fundamentals. The current price is €3.32.
What is the quality score of ALTHX?
THX Pharma Société Anonyme, a biopharmaceutical company, has a Quality Score of 82/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.